Han et al., 2016 - Google Patents
Antibodies to the DNA-directed RNA polymerase II subunit RPB1 occur with highest frequency in centenariansHan et al., 2016
View HTML- Document ID
- 4250780547570687857
- Author
- Han J
- Park S
- Kim D
- Kim H
- Choi Y
- Lee J
- Park S
- Chung J
- Publication year
- Publication venue
- Immunity & Ageing
External Links
Snippet
Background Recently, phage display technology has made it possible to define the circulating repertoire of humoral immunity. This study was designed to define the circulating antibodies specific to centenarians. Results We used a phage-displayed combinatorial …
- 102000004965 antibodies 0 title abstract description 26
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Trier et al. | Peptides, antibodies, peptide antibodies and more | |
| Monach et al. | A broad screen for targets of immune complexes decorating arthritic joints highlights deposition of nucleosomes in rheumatoid arthritis | |
| Mahler et al. | Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies | |
| George et al. | Differential Effects of Anti–β2-Glycoprotein I Antibodies on Endothelial Cells and on the Manifestations of Experimental Antiphospholipid Syndrome | |
| Goldsteins et al. | Exposure of cryptic epitopes on transthyretin only in amyloid and in amyloidogenic mutants | |
| Kawa et al. | A novel immunoglobulin-immunoglobulin interaction in autoimmunity | |
| Zheng et al. | Disordered antigens and epitope overlap between anti–citrullinated protein antibodies and rheumatoid factor in rheumatoid arthritis | |
| Reijm et al. | Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational load | |
| Strachan et al. | Rapid selection of anti-hapten antibodies isolated from synthetic and semi-synthetic antibody phage display libraries expressed in Escherichia coli | |
| Miske et al. | Autoantibodies against the purkinje cell protein RGS8 in paraneoplastic cerebellar syndrome | |
| Satoh et al. | Autoantibodies to transcription intermediary factor (TIF) 1β associated with dermatomyositis | |
| Al Kindi et al. | Secreted autoantibody repertoires in Sjögren's syndrome and systemic lupus erythematosus: a proteomic approach | |
| Ogawa et al. | Association of antibodies to the NR1 subunit of N-methyl-D-aspartate receptors with neuropsychiatric systemic lupus erythematosus | |
| Xia et al. | A peptide mimic blocks the cross-reaction of anti-DNA antibodies with glomerular antigens | |
| Que et al. | IGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde–acetaldehyde adduct, an immunodominant oxidation-specific epitope | |
| Okawa-Takatsuji et al. | Endothelial cell-binding activity of anti-U1-ribonucleoprotein antibodies in patients with connective tissue diseases | |
| Mahler et al. | Clinical and serological associations of autoantibodies to the Ku70/Ku80 heterodimer determined by a novel chemiluminescent immunoassay | |
| Corsiero et al. | Characterization of a synovial B cell–derived recombinant monoclonal antibody targeting stromal calreticulin in the rheumatoid joints | |
| Han et al. | Antibodies to the DNA-directed RNA polymerase II subunit RPB1 occur with highest frequency in centenarians | |
| Gora et al. | Evaluation of conformational epitopes on thyroid peroxidase by antipeptide antibody binding and mutagenesis | |
| Takheaw et al. | The presence of membrane bound CD99 ligands on leukocyte surface | |
| Sharma et al. | Studies of human polyclonal and monoclonal antibodies binding to lupus autoantigens and cross‐reactive antigens | |
| Siapka et al. | Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen | |
| Bondarenko et al. | Identification of critical chemical modifications and paratope mapping by size exclusion chromatography of stressed antibody-target complexes | |
| Caponi et al. | Anti-ribosomal antibodies from lupus patients bind DNA |